Observing cancer relapse and quality of life after kidney surgery
2014 Transizionali - Observational Study on the Occurrence of Relapses and on the Quality of Life in Patients Who Underwent Nephroureterectomy Surgery
This study looks at how kidney surgery affects cancer relapse and the overall quality of life for patients with a specific type of urinary tract cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan, MI) |
| Trial ID | NCT06169436 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who have undergone nephroureterectomy surgery for upper urinary tract urothelial carcinoma. It aims to collect both prospective and retrospective data on oncological relapse, clinical progression, and quality of life, including psychological and sexual health aspects. A dedicated database will facilitate secure data extraction for statistical analysis, enhancing the understanding of patient outcomes and informing future therapeutic strategies. The study will utilize clinical reports from patients treated since 1987 to enrich the data set.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with upper tract urothelial cancer who are indicated for nephroureterectomy surgery.
Not a fit: Patients under 18 years old or those without a diagnosis of upper tract urothelial cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve patient care and treatment strategies for those with upper urinary tract urothelial carcinoma.
How similar studies have performed: Other studies have shown success in observing quality of life and relapse in cancer patients, making this approach both relevant and supported by existing literature.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Upper tract urothelial cancer diagnosis * Indication to cancer removal through nephroureterectomy surgery * Ability to read and sign the informed consent Exclusion Criteria: * Age \< 18 years * Absence of upper tract urothelial cancer * Inability to read and sign the informed consent
Where this trial is running
Milan, MI
- IRCCS Ospedale San Raffaele — Milan, Mi, Italy (Recruiting)
Study contacts
- Principal investigator: Francesco Montorsi, MD — IRCCS Ospedale San Raffaele
- Study coordinator: Francesco Montorsi, MD.
- Email: montorsi.francesco@hsr.it
- Phone: 02 2643 7286
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.